APA (7th ed.) Citation

Langbein, B., Labban, M., Chen, X., Reese, S., Lipsitz, S., McNabb-Baltar, J., . . . Trinh, Q. (2022). 872P Ipilimumab-induced gastrointestinal and hepatic immune-related adverse events: A national cohort. Annals of Oncology, 33, S948. https://doi.org/10.1016/j.annonc.2022.07.998

Chicago Style (17th ed.) Citation

Langbein, B., M. Labban, X. Chen, S. Reese, S. Lipsitz, J. McNabb-Baltar, M. Sun, A. Cole, and Q-D Trinh. "872P Ipilimumab-induced Gastrointestinal and Hepatic Immune-related Adverse Events: A National Cohort." Annals of Oncology 33 (2022): S948. https://doi.org/10.1016/j.annonc.2022.07.998.

MLA (9th ed.) Citation

Langbein, B., et al. "872P Ipilimumab-induced Gastrointestinal and Hepatic Immune-related Adverse Events: A National Cohort." Annals of Oncology, vol. 33, 2022, p. S948, https://doi.org/10.1016/j.annonc.2022.07.998.